GlutathioneS-Transferase-Mediated Mutagenicity of Trihalomethanes inSalmonella typhimurium:Contrasting Results with Bromodichloromethane and Chloroform

Andersen, 1987, Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicol. Appl. Pharmacol., 87, 185, 10.1016/0041-008X(87)90281-X Bowman, 1978, The toxicity of some halomethanes in mice, Toxicol. Appl. Pharmacol., 44, 213, 10.1016/0041-008X(78)90300-9 Butterworth, 1992, Chemically-induced cell proliferation in carcinogenesis Cantor, 1978, Associations of cancer mortality with halomethanes in drinking water, J. Natl. Cancer Inst., 4, 979 Chu, 1980, The acute toxicity of four trihalomethanes in male and female rats, Toxicol. Appl. Pharmacol., 52, 351, 10.1016/0041-008X(80)90122-2 Colacci, 1991, Chloroform bioactivation leading to nucleic acids binding, Tumori, 77, 285, 10.1177/030089169107700401 Corley, 1990, Development of a physiologically based pharmacokinetic model for chloroform, Toxicol. Appl. Pharmacol., 103, 512, 10.1016/0041-008X(90)90324-N Dechert, 1996, The possible role ofS, Toxicologist, 30, 93 Dunnick, 1987, Bromodichloromethane, a trihalomethane that produces neoplasms in rodents, Cancer Res., 47, 5189 Fujie, 1990, Acute and subacute cytogenetic effects of the trihalomethanes on rat bone marrow cellsin vivo, Mutat. Res., 242, 111, 10.1016/0165-1218(90)90036-2 Graves, 1995, Methylene chloride-induced DNA damage: An interspecies comparison, Carcinogenesis, 16, 1919, 10.1093/carcin/16.8.1919 Graves, 1996, Mouse liver glutathioneS, Mutat. Res., 367, 143, 10.1016/0165-1218(95)00087-9 Graves, 1996, DNA sequence analysis of methylene chloride-induced HPRT mutations in Chinese hamster ovary cells: Comparison with the mutation spectrum obtained for 1,2-dibromoethane and formaldehyde, Mutagenesis, 11, 229, 10.1093/mutage/11.3.229 Hashmi, 1994, Bioactivation of [1313, Chem. Res. Toxicol., 7, 291, 10.1021/tx00039a004 Hughes, 1987, Vaporization technique to measure mutagenic activity of volatile organic chemicals in the Ames/Salmonella, Environ. Mutagen., 9, 421, 10.1002/em.2860090408 1994, Environmental Health Criteria 163: Chloroform 1991 Jorgenson, 1985, Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice, Fundam. Appl. Toxicol., 5, 760, 10.1016/0272-0590(85)90200-3 Koch, 1994, Salmonella typhimurium, Carcinogenesis, 15, 79, 10.1093/carcin/15.1.79 Krasner, 1989, The occurrence of disinfection by-products in U.S. drinking water, J. Am. Water Works Assoc., 81, 41, 10.1002/j.1551-8833.1989.tb03258.x Kroll, 1994, Characterization of trihalomethane (THM)-induced renal dysfunction in the rat. II. Relative potency of THMs in promoting renal dysfunction, Arch. Environ. Contam. Toxicol., 27, 5 Larson, 1993, Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice, Fundam. Appl. Toxicol., 20, 302, 10.1006/faat.1993.1040 Larson, 1994, Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vsad libitum, Fundam. Appl. Toxicol., 22, 90, 10.1006/faat.1994.1012 Larson, 1994, Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage, Fundam. Appl. Toxicol., 23, 537, 10.1006/faat.1994.1138 Lilly, 1996, A physiologically-based pharmacokinetic description of bromodichloromethane tissue dosimetry and metabolism, Toxicologist, 30, 251 Lilly, 1994, Dose-dependent vehicle differences in the acute toxicity of bromodichloromethane, Fundam. Appl. Toxicol., 23, 132, 10.1006/faat.1994.1089 Lilly, 1994, Comparative renal and hepatic toxicity of bromodichloromethane (BDCM) and chloroform (CHCl3, Toxicologist, 14, 280 Maron, 1983, Revised methods for theSalmonella, Mutat. Res., 113, 173, 10.1016/0165-1161(83)90010-9 Meyer, 1991, Theta, a new class of glutathione transferases purified from rat and man, Biochem. J., 247, 409, 10.1042/bj2740409 Morris, 1992, Chlorination, chlorination by-products, and cancer: A meta-analysis, Am. J. Public Health, 7, 955, 10.2105/AJPH.82.7.955 National Cancer Institute, 1976, Report on the Carcinogenesis Bioassay of Chloroform, NCI, Bethesda, MD 1987, Toxicology and Carcinogenesis Studies of Bromodichloromethane in F344/N Rats and B6C3F1 Mice (Gavage Studies) Pohl, 1977, Phosgene: A metabolite of chloroform, Biochem. Biophys. Res. Commun., 79, 684, 10.1016/0006-291X(77)91166-4 Reitz, 1990, Estimating the risk of liver cancer associated with human exposures to chloroform, Toxicol. Appl. Pharmacol., 105, 443, 10.1016/0041-008X(90)90148-N Rosenthal, 1987, A review of the mutagenicity of chloroform, Environ. Mol. Mutagen., 10, 199, 10.1002/em.2850100212 Schroder, 1992, Dissociation of a new glutathione S-transferase activity in human erythrocytes, Biochem. Pharmacol., 43, 1671, 10.1016/0006-2952(92)90695-F Simula, 1993, Human glutathione S-transferase-expressingSalmonella typhimurium1, Carcinogenesis, 14, 1371, 10.1093/carcin/14.7.1371 Testai, 1990, Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice, Toxicol. Appl. Pharmacol., 104, 496, 10.1016/0041-008X(90)90171-P Thier, 1993, Expression of mammalian glutathioneSSalmonella typhimurium, Proc. Natl. Acad. Sci. USA, 90, 8576, 10.1073/pnas.90.18.8576 Thier, 1996, Human glutathioneSSalmonella typhimurium, Carcinogenesis, 17, 163, 10.1093/carcin/17.1.163 Thornton-Manning, 1994, Toxicity of bromodichloromethane in female rats and mice after repeated oral dosing, Toxicology, 94, 3, 10.1016/0300-483X(94)90024-8 Tomasi, 1985, Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique, Chem.-Biol. Interact., 55, 303, 10.1016/S0009-2797(85)80137-X U.S. Environmental Protection Agency, 1994, Drinking Water Criteria for Trihalomethanes, Office of Water, U.S. EPA